Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014-2015).
Disease
Linezolid
MRSA
Oxazolidinones
Surveillance
VRE
Journal
Journal of chemotherapy (Florence, Italy)
ISSN: 1973-9478
Titre abrégé: J Chemother
Pays: England
ID NLM: 8907348
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
pubmed:
14
5
2019
medline:
18
12
2019
entrez:
14
5
2019
Statut:
ppublish
Résumé
Activities of tedizolid and comparators were evaluated against gram-positive isolates responsible for skin and skin structure infections, pneumonia, and bloodstream infections. Non-duplicate gram-positive isolates (8011) were collected from 20 European countries/regions. Tedizolid (0.12 mg/L) showed similar results of minimum inhibitory concentration required to inhibit the growth of 50% of organisms (MIC
Identifiants
pubmed: 31079589
doi: 10.1080/1120009X.2019.1609740
doi:
Substances chimiques
Anti-Bacterial Agents
0
Oxazolidinones
0
Tetrazoles
0
tedizolid
97HLQ82NGL
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM